Crossref
In adults with mild cognitive impairment (MCI) or dementia, how does ginkgo biloba compare with placebo?
Cochrane Clinical Answers · 29.07.2026
DOI: 10.1002/cca.4803 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cochrane Clinical Answers, online erschienen am 29.07.2026. Verfasst von Agustín Ciapponi. Die Arbeit nennt 48 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ciapponi, A. (2026). In adults with mild cognitive impairment (MCI) or dementia, how does ginkgo biloba compare with placebo?. Cochrane Clinical Answers. https://doi.org/10.1002/cca.4803
Vancouver
Ciapponi A. In adults with mild cognitive impairment (MCI) or dementia, how does ginkgo biloba compare with placebo?. Cochrane Clinical Answers. 2026. doi:10.1002/cca.4803
BibTeX
@article{Ciapponi2026,
author = {Ciapponi, Agustín},
title = {In adults with mild cognitive impairment (MCI) or dementia, how does ginkgo biloba compare with placebo?},
journal = {Cochrane Clinical Answers},
year = {2026},
doi = {10.1002/cca.4803}
}
EUVIMED